Tur MK - Search Results

1

A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells.

Lilienthal N, Lohmann G, Crispatzu G, Vasyutina E, Zittrich S, Mayer P, Herling CD, Tur MK, Hallek M, Pfitzer G, Barth S, Herling M. Lilienthal N, et al. Among authors: tur mk. Mol Cancer Ther. 2016 May;15(5):971-84. doi: 10.1158/1535-7163.MCT-15-0685. Epub 2016 Jan 29. Mol Cancer Ther. 2016. PMID: 26826117

2

In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.

Tur MK, Huhn M, Jost E, Thepen T, Brümmendorf TH, Barth S. Tur MK, et al. Int J Cancer. 2011 Sep 1;129(5):1277-82. doi: 10.1002/ijc.25766. Epub 2011 Feb 26. Int J Cancer. 2011. PMID: 21077160

3

An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.

Hussain AF, Tur MK, Barth S. Hussain AF, et al. Among authors: tur mk. Nucleic Acid Ther. 2013 Jun;23(3):203-12. doi: 10.1089/nat.2012.0408. Epub 2013 Apr 1. Nucleic Acid Ther. 2013. PMID: 23544955

4

Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.

Tur MK, Daramola AK, Gattenlöhner S, Herling M, Chetty S, Barth S. Tur MK, et al. Biomedicines. 2017 Oct 4;5(4):59. doi: 10.3390/biomedicines5040059. Biomedicines. 2017. PMID: 28976934 Free PMC article. Review.

5

Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion protein.

Brehm H, Hristodorov D, Pardo A, Mladenov R, Niesen J, Fischer R, Tur MK, Barth S. Brehm H, et al. Among authors: tur mk. Cancer Lett. 2015 Sep 1;365(2):149-55. doi: 10.1016/j.canlet.2015.04.004. Epub 2015 Apr 14. Cancer Lett. 2015. PMID: 25888452

6

Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.

Tur MK, Neef I, Jost E, Galm O, Jäger G, Stöcker M, Ribbert M, Osieka R, Klinge U, Barth S. Tur MK, et al. J Immunother. 2009 Jun;32(5):431-41. doi: 10.1097/CJI.0b013e31819f1cb6. J Immunother. 2009. PMID: 19609235

7

Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy.

Tur MK, Neef I, Jäger G, Teubner A, Stöcker M, Melmer G, Barth S. Tur MK, et al. Curr Pharm Des. 2009;15(23):2693-9. doi: 10.2174/138161209788923877. Curr Pharm Des. 2009. PMID: 19689339 Review.

8

SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.

Hussain AF, Kampmeier F, von Felbert V, Merk HF, Tur MK, Barth S. Hussain AF, et al. Among authors: tur mk. Bioconjug Chem. 2011 Dec 21;22(12):2487-95. doi: 10.1021/bc200304k. Epub 2011 Nov 3. Bioconjug Chem. 2011. PMID: 21995499

9

Short-chain fluorescent tryptophan tags for on-line detection of functional recombinant proteins.

Siepert EM, Gartz E, Tur MK, Delbrück H, Barth S, Büchs J. Siepert EM, et al. Among authors: tur mk. BMC Biotechnol. 2012 Sep 21;12:65. doi: 10.1186/1472-6750-12-65. BMC Biotechnol. 2012. PMID: 22999206 Free PMC article.

10

Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes.

Stahnke B, Thepen T, Stöcker M, Rosinke R, Jost E, Fischer R, Tur MK, Barth S. Stahnke B, et al. Among authors: tur mk. Mol Cancer Ther. 2008 Sep;7(9):2924-32. doi: 10.1158/1535-7163.MCT-08-0554. Mol Cancer Ther. 2008. PMID: 18790773 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters